Biohaven Pharmaceutical Holding Market Cap 2016-2022 | BHVN
Biohaven Pharmaceutical Holding market cap history and chart from 2016 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Biohaven Pharmaceutical Holding market cap as of August 10, 2022 is $10.53B.
||Medical - Biomedical and Genetics
Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.